Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Related Concept Videos

Transmission-based Precautions II: Airborne and Protective Environment

Transmission-based Precautions II: Airborne and Protective Environment

Transmission-based precautions are for patients infected or suspected to be infected (or colonized) with organisms posing a significant risk to others. The transmission precautions include airborne and protective environment precautions.
Airborne precautions:
Use airborne precautions when treating patients known or suspected to have diseases that spread through the air—for example, tuberculosis or measles. These organisms are present in smaller droplets expelled by an infected person and...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

Particle Phagocytosis Amplifies Secretion of Small Extracellular Vesicles in Macrophages.

bioRxiv : the preprint server for biology·2026

Same author

High-throughput bioprinted 3D cultures for probing host-pathogen interactions in bioinspired microenvironments.

RSC applied polymers·2026

Same author

The Complexation Properties of Self-Defensive Microgel-Modified Antimicrobial Surfaces.

ACS applied bio materials·2026

Same author

Macrophage variance: investigating how macrophage origin influences responses to soluble and physical cues with immortalized vs. primary cells in 2D and 3D culture.

Frontiers in biomaterials science·2025

Same author

Bio-functional hydrogel coated membranes to decrease T-cell exhaustion in manufacturing of CAR T-cells.

Frontiers in immunology·2025

Same author

Nanoparticle-Based Pulmonary Immune Engineering.

Annual review of chemical and biomolecular engineering·2025

Same journal

Silicone oil in protein drug products and its implications for formulation stability.

Advanced drug delivery reviews·2026

Same journal

Targeted delivery of proteolysis-targeting chimeras (PROTAC) and molecular glue degraders (MGD).

Advanced drug delivery reviews·2026

Same journal

Lysosome-targeting degrader delivery system: from formulation design to biomedical applications.

Advanced drug delivery reviews·2026

Same journal

Anti-PEG antibodies in nanomedicine: Mechanisms, risks, and opportunities.

Advanced drug delivery reviews·2026

Same journal

Optimizing macrophage-targeted intracellular delivery systems for safe and effective immunotherapies.

Advanced drug delivery reviews·2026

Same journal

Light-controlled CRISPR-dCas9 epigenome editing: advanced drug-delivery strategies and oncology applications.

Advanced drug delivery reviews·2026

See all related articles

Search research articles

Related Experiment Video

Updated: Aug 1, 2025

An Air-liquid Interface Bronchial Epithelial Model for Realistic, Repeated Inhalation Exposure to Airborne Particles for Toxicity Testing

An Air-liquid Interface Bronchial Epithelial Model for Realistic, Repeated Inhalation Exposure to Airborne Particles for Toxicity Testing

Published on: May 13, 2020

Aerosol pulmonary immune engineering.

Emma R Sudduth¹, Michael Trautmann-Rodriguez¹, Nicole Gill¹

¹Department of Chemical and Biomolecular Engineering, University of Delaware, Newark, DE 19716, USA.

Advanced Drug Delivery Reviews

|April 26, 2023

Summary

This summary is machine-generated.

Inhaled immunotherapies offer a promising way to treat lung diseases by directly targeting the lung

Keywords:

Asthma Biologics COPD COVID-19 Cancer Cystic fibrosis Immune engineering Immunotherapy Particulates Pulmonary delivery Small molecules

More Related Videos

A Method for Generating Pulmonary Neutrophilia Using Aerosolized Lipopolysaccharide

A Method for Generating Pulmonary Neutrophilia Using Aerosolized Lipopolysaccharide

Published on: December 15, 2014

Whole-Body Nanoparticle Aerosol Inhalation Exposures

Whole-Body Nanoparticle Aerosol Inhalation Exposures

Published on: May 7, 2013

Related Experiment Videos

Last Updated: Aug 1, 2025

An Air-liquid Interface Bronchial Epithelial Model for Realistic, Repeated Inhalation Exposure to Airborne Particles for Toxicity Testing

An Air-liquid Interface Bronchial Epithelial Model for Realistic, Repeated Inhalation Exposure to Airborne Particles for Toxicity Testing

Published on: May 13, 2020

A Method for Generating Pulmonary Neutrophilia Using Aerosolized Lipopolysaccharide

A Method for Generating Pulmonary Neutrophilia Using Aerosolized Lipopolysaccharide

Published on: December 15, 2014

Whole-Body Nanoparticle Aerosol Inhalation Exposures

Whole-Body Nanoparticle Aerosol Inhalation Exposures

Published on: May 7, 2013

Area of Science:

Pulmonary immunology
Drug delivery systems
Immunoengineering

Background:

Aerosolized immunotherapies can modulate the lung's immune environment and cellular defenses.
Targeting mucosal-associated lymphoid tissue can influence systemic immune responses.

Purpose of the Study:

To review immunoengineering strategies for inhaled immunotherapies in pulmonary disorders.
To discuss formulation, delivery, and immune modification advantages of various platforms.

Main Methods:

Literature review of historical and novel inhaled immunotherapy approaches.
Analysis of small molecules, biologics, particulates, cell therapies, and vaccines.
Examination of formulation design and preclinical models.

Main Results:

Inhalable immunoengineering encompasses diverse platforms from small molecules to cell therapies.
Formulation design is critical for effective aerosol delivery and immune response.
Various platforms offer distinct advantages for desired immune modifications.

Conclusions:

Inhaled immunotherapies present a powerful strategy for treating inflammatory lung diseases.
Further research into clinical translation of these platforms is warranted.